Dabur: In the reckoning - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dabur: In the reckoning

Aug 31, 2000

Dabur India, the 115 year old FMCG ‘ayurvedic’ company operates in the niche natural/ayurvedic products segment with a product folio of over 500 products. Its core competence lies in its ability to conceive, develop and market products based on herbs and natural resources. Its product portfolio includes major brands like Dabur Chyawanprash, Hajmola, Pudin Hara, Lal Dant Manjan, Amla, Vatika hair oils, Real fruit juice, Dabur Honey, all of which are market leaders in their respective segments. It is also a leading player in the anti-cancer segment and was the first company in India to have developed the anti-cancer intermediary DAB-10 and its associated drug paclitaxel (Taxol). But despite its range, investors have been wary of investing in this company simply because of its unrelated diversifications and a family run business. To counter this, Dabur undertook a restructuring exercise about a couple of years ago, based on McKinsey recommendations. As a result, it decided to spin off non-core businesses and inducted an all-new professional management team.

The markets took notice of these initiatives and stock price climbed. But lately, Dabur has been facing the music on the bourses. The company’s stock is quoting at Rs 690 levels, which is 25.7 times its FY2000 earnings. At its 52 week peak, the company quoted at a P/e multiple of over 60 times.

This is despite a 53% growth in net profit for the year ended March 2000 over the previous year. The growth in sales amounted to 13.4%. This is by any yardstick a creditable performance when most FMCG companies (including HLL) are clocking single digit turnover growth. Its margins also showed a marked improvement over the previous year. However, in its first quarter the company has shown signs of slowing down. Turnover growth slowed to 7%, compared to a 19% growth in 1QFY99. But its profits logged in a 33% growth, showing signs of improving margins. So it’s showing has been decent.

But there are some concerns. Lately, the company has again been dabbling in diversifications, like its proposed foray into life insurance (in partnership with US insurance company Allstate). Dabur is entering processed milk segment via its joint venture company Dabon. The company has also downgraded its earnings estimates and has stated that it will be unable to achieve the sales target of Rs 20 bn by FY2003 ( FY2000 turnover = Rs 10.8 bn).

However, such issues notwithstanding, the company’s presence in a niche industry of ayurveda products, strong brands, and diverse product portfolio, backed by strong research, serves as an entry barrier for new entrants and is difficult to replicate. One should take into account Dabur’s extensive distribution reach (over 600,000 retailers) in India. Moreover, the company’s management looks committed to improving the company’s core operations by getting out of low margin businesses and pruning the debt burden.

Bottomline, it is time for a relook.

Equitymaster requests your view! Post a comment on "Dabur: In the reckoning". Click here!

  

More Views on News

DABUR 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of DABUR for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DABUR. Also includes updates on the valuation of DABUR.

DABUR Announces Quarterly Results (1QFY22); Net Profit Up 28.4% (Quarterly Result Update)

Aug 5, 2021 | Updated on Aug 5, 2021

For the quarter ended June 2021, DABUR has posted a net profit of Rs 4 bn (up 28.4% YoY). Sales on the other hand came in at Rs 26 bn (up 31.9% YoY). Read on for a complete analysis of DABUR's quarterly results.

Dabur India Shares Hit New Record High. What's Fueling the Rally? (Views On News)

Jul 1, 2021

Dabur India shares hit a record high of Rs 592.3 on the back of robust growth outlook.

Adani Wilmar IPO to Hit the Market Soon. Should you Apply? (Views On News)

Nov 29, 2021

The parent company of the brand Fortune is set to raise Rs 45 bn from the market.

What Happens if ITC Hives off ITC Infotech? (Views On News)

Nov 20, 2021

The cigarette to hotel conglomerate is reportedly mulling the demerger of its software business at a valuation of around Rs 250 bn.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DABUR SHARE PRICE


Nov 30, 2021 (Close)

TRACK DABUR

DABUR - MILESTONE FURNITURE COMPARISON

COMPARE DABUR WITH

MARKET STATS